Pfizer and BioNTech plan to double the supply of the COVID-19 vaccine to the U.S. government at a nonprofit price, to 1 billion doses. An additional 500 million doses will be delivered by the end of September 2022. The government, in turn, will donate these doses to low- and middle-income countries.
Pfizer and BioNTech plan to double the supply of the COVID-19 vaccine to the U.S. government at a nonprofit price, to 1 billion doses. An additional 500 million doses will be delivered by the end of September 2022. The government, in turn, will donate these doses to low- and middle-income countries. 
investors.biontech.de
English (US) 